Today: 20 May 2026

AT&T stock price slips into Presidents Day break as Fed minutes loom

AT&T stock price slips into Presidents Day break as Fed minutes loom

AT&T shares closed down 0.4% at $28.69 Friday, trimming gains from earlier in the week as traders positioned ahead of the Presidents Day holiday. Verizon fell 0.9% while T-Mobile rose 2.3%. Cooler January inflation data pushed Treasury yields lower, reviving rate-cut bets. AT&T recently completed a $5.75 billion deal for Lumen’s fiber business, adding over 1 million fiber subscribers.
14 February 2026
··
Expedia stock drops on cautious 2026 margins — what to watch when EXPE trading resumes

Expedia stock drops on cautious 2026 margins — what to watch when EXPE trading resumes

Expedia shares fell 6.6% to $212.67 Friday after the company issued a softer full-year margin outlook despite raising its dividend and forecasting higher 2026 bookings and revenue. Fourth-quarter gross bookings rose 11% to $27 billion and revenue hit $3.55 billion. Several analysts cut price targets following the results. U.S. markets are closed Monday for Presidents Day.
14 February 2026
··
KLA stock in focus: KLAC heads into holiday week after $400 million India R&D pact

KLA stock in focus: KLAC heads into holiday week after $400 million India R&D pact

KLA Corp shares rose 0.92% to $1,464.13 Friday after announcing a deal with Tamil Nadu to build a major R&D campus in Chennai. The company plans to invest up to $400 million over 10 years, with the site expected to create up to 4,000 skilled jobs. The project will focus on AI-driven semiconductor technologies and process control tools, according to company and state officials.
14 February 2026
···
GE Aerospace stock price: repair robots, engine shortages and Airbus supply pressure in focus

GE Aerospace stock price: repair robots, engine shortages and Airbus supply pressure in focus

GE Aerospace shares rose 0.8% to $315.41 Friday as the company expanded automation and Lean methods to boost jet-engine repair output. GE has begun using robots for precision repairs at its Singapore hub to clear backlogs. Safran, GE’s CFM partner, forecast higher 2026 profits on civil engine demand. Airbus continues to press CFM for increased LEAP engine deliveries amid ongoing supply chain strains.
14 February 2026
···
Vertex stock jumps nearly 6% on Oppenheimer upgrade as traders size up new drug pipeline

Vertex stock jumps nearly 6% on Oppenheimer upgrade as traders size up new drug pipeline

Vertex shares jumped 5.7% to $491.47 Friday after Oppenheimer upgraded the stock, citing growth plans beyond cystic fibrosis. The company set 2026 revenue guidance at up to $13.1 billion, with at least $500 million expected from new products. Vertex highlighted gene-editing, pain, and kidney therapies in its outlook. U.S. markets close Monday for Presidents Day.
14 February 2026
··
Snowflake stock (SNOW) jumps 5% into long weekend as AI nerves and earnings near

Snowflake stock (SNOW) jumps 5% into long weekend as AI nerves and earnings near

Snowflake shares jumped 5.4% to $182.29 Friday after a previous drop, with trading volume at 8.33 million shares. The move followed lower Treasury yields and U.S. inflation data that fueled bets on Fed rate cuts. Snowflake recently announced a $200 million OpenAI partnership and a deal with U.S. Figure Skating. The company reports earnings after market close on Feb. 25.
14 February 2026
····
1 … 255 256 257 258 259 … 1,957

Stock Market Today

  • Parabilis Plans IPO to Fund Phase 3 Trial for Tumor Drug Following Regeneron Deal
    May 20, 2026, 5:56 AM EDT. Parabilis Medicines, a Massachusetts biotech, is preparing for an initial public offering (IPO) to finance the phase 3 trial of its tumor drug zolucatetide, targeting rare desmoid tumors. The drug, which inhibits the Wnt/β-catenin pathway implicated in many cancers, recently received FDA fast-track status. Proceeds will also support phase 1 trials for additional cancers. Parabilis secured a $50 million upfront payment and a $75 million equity investment from Regeneron in a deal to explore Parabilis' helicon peptide platform. The firm boasts over $300 million in cash from prior funding rounds. CEO Mathai Mammen aims to grow Parabilis into a fully integrated research, development, manufacturing, and commercialization company, relying on partnerships to finance its ambitions.

Latest articles

San Antonio’s New Battery Bet Comes Just as CPS Outages Get Longer

San Antonio’s New Battery Bet Comes Just as CPS Outages Get Longer

20 May 2026
OCI Energy and CPS Energy have begun building a 120-megawatt battery storage facility in southeastern Bexar County, aiming for commercial operation in 2027. The project follows a rise in average outage duration for CPS Energy customers to 75.38 minutes in 2025. OCI will own the facility, with CPS holding operational control. ING is financing construction, and LG Energy Solution Vertech is supplying batteries.
Co-Diagnostics Jumps; $3 Million Deal Looms

Co-Diagnostics Jumps; $3 Million Deal Looms

20 May 2026
Co-Diagnostics announced a $3 million private placement after its stock surged 43.8% Tuesday, then fell 13.3% in after-hours trading. The company will sell 1.65 million shares or pre-funded warrants, plus warrants for up to 3.29 million more shares, nearly doubling its share count. The move follows its completion of a Bundibugyo virus assay as Ebola spreads in Congo and Uganda. Co-Diagnostics reported $8.2 million in cash at March 31.
Micron Stock Just Dodged the Nasdaq Selloff. A Samsung Strike Could Be Its Next Jolt

Micron Stock Just Dodged the Nasdaq Selloff. A Samsung Strike Could Be Its Next Jolt

20 May 2026
Micron Technology shares rose 2.5% Tuesday to $698.74, lifting its market value near $798 billion as the Nasdaq fell. Analysts cited tight memory supply and strong DRAM and NAND pricing. A planned strike by 48,000 Samsung workers Thursday could disrupt global memory supply, potentially raising prices. Micron recently sampled 256GB DDR5 server modules to partners.
Go toTop